HOLLYWOOD, Calif., April 12, 2012 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) announced today that their status has been upgraded on the Over the Counter Markets (OTC) to "Pink Current."
The company had been listed on the OTC Pink Limited Tier due to incomplete financial filings under the company's previous management. Those filings are now complete and current, which prompted the upgrade in the OTC Tier status.
"We took over this public company about six months ago and have worked diligently to prepare all required filings, create transparency in our operation, and obtain full compliance with all regulations," stated Vincent Mehdizadeh, CEO and Founder of Prescription Vending Machines, Inc. a Subsidiary of Medbox. "We look forward to continuing to build an environment that creates investor confidence and growth opportunities."
Medbox, Inc. is also scheduled to release their 1st Quarter Financials within the next few days, which will show a record amount of income and the highest ever quarterly revenues for the company and its subsidiaries.
For more information, please visit www.medboxinc.com.
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.
Medbox, Inc. is a publicly traded company. Its common stock trades on the Over-the-Counter Market (OTC), ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
SOURCE Medbox, Inc.